Barclays raised the firm’s price target on P10 (PX) to $16 from $15 and keeps an Overweight rating on the shares as part of a Q4 earnings preview for asset managers. The firm says we continue to get closer to a “normal” market environment, with the initial public offering and merger markets “showing signs of life though it seems we are still in a ramping period.”
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.